--

Dr Christos TOUMPANAKIS MD, PhD, FRCP, FEBGH, AGAF is a Consultant in Gastroenterology & Neuroendocrine Tumours (NET) at the Neuroendocrine Tumour Unit – ENETS Centre of Excellence of Royal Free Hospital, London, UK, since 2007. He is also an Honorary Associate Professor at University College of London (UCL) and has been awarded 7 times, as "Top-Teacher of the Year". He graduated from Medical School-University of Athens, Greece in 1994, obtained his Specialty Title in Gastroenterology & Hepatology in 2004, and his PhD from University of Athens in 2007. He has been involved in the area of NET since 2000. He is lecturing on a regular basis in several National & International Conferences and published > 100 original papers and Reviews.

He is the Chair of the Advisory Board of the European Neuroendocrine Tumour Society (ENETS), co-Chair of the Post-Graduate Course of ENETS annual Conference, co-Editor of ENETS CME program, co-Author of UK and Ireland NET Society & European NET Society Guidelines, associate Editor of "Journal of Neuroendocrinology", as well as a member of the Advisory Board of the "UK NET patients' foundation".

He is leading a NET Clinical Research Group, involving Junior Doctors and UCL Medical Students in NET Clinical research projects. His main research interests include novel NET biomarkers, molecular imaging in NETs, and carcinoid heart disease. In 2014, he organized the 1st International Conference for "Carcinoid Heart Disease" in London, which led to the development of an International Network of experts, who published the first ever International management guidelines for Carcinoid Heart Disease in March 2017.

Apart from NET, Dr Toumpanakis sees patients with all general gastrointestinal conditions including gastro-oesophageal reflux disease, celiac disease, chronic diarrhoea, Inflammatory Bowel Disease and gastrointestinal problems in patients with congenital immuno-deficiencies.